Загрузка...
Atezolizumab in patients with renal insufficiency and mixed variant histology: analyses from an expanded access program in platinum-treated locally advanced or metastatic urothelial carcinoma
BACKGROUND: Atezolizumab is a treatment for locally advanced/metastatic urothelial carcinoma (mUC). However, its use in patients with renal insufficiency or UC with mixed variant histology (MVH) is not well characterized. OBJECTIVE: To report efficacy and safety of atezolizumab in these special subp...
Сохранить в:
| Опубликовано в: : | J Immunother Cancer |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BMJ Publishing Group
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7342864/ https://ncbi.nlm.nih.gov/pubmed/32641319 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jitc-2019-000419 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|